A molecule identified by Karolinska Institutet researchers promotes intestinal healing and suppresses colorectal cancer tumor ...

A research team at the University of Vienna, led by medicinal chemist Markus Muttenthaler, has developed a new class of oral ...

Migraines are more than just bad headaches; they stem from a genetic neurological disease that causes suffering for one in ...

Lilly will provide the funding and expertise to advance Laekna’s LAE102, a first-in-class monoclonal antibody targeting the ...

In recent years, ketamine — long known for its misuse as a psychedelic party drug — has become a “life-saving” medicine for ...

Immune cells are capable of detecting infections just like a sniffer dog, using special sensors known as Toll-like receptors, or TLRs for short. But what signals activate TLRs, and what is the ...

A research team behind a new study at the Hebrew University of Jerusalem has made an important breakthrough in understanding ...

A new study provides important insights into how T-cells, a type of immune cell, become activated. Researchers employed a ...

SOUTH SAN FRANCISCO, Calif., Nov. 20, 2024 (GLOBE NEWSWIRE) -- Septerna, Inc. (Nasdaq: SEPN), a clinical-stage biotechnology company pioneering a new era of G protein-coupled receptor (GPCR) drug ...

Researchers from Naya Biosciences Inc. and collaborators presented preclinical data on NY-303, a natural killer (NK) cell engager bispecific antibody targeting both GPC3 and NKp46. NKp46 is a cell ...

Ozempic, Wegovy and Mounjaro are often the most popular weight loss drugs. While these medications help people lose weight, ...

Researchers have developed a new class of oral painkillers to suppress chronic abdominal pain that is based on the peptide hormone oxytocin that drives childbirth contractions.